Submit Your Feeds

Business News • PR NewsWire • Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results

Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results
Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results

NEW ORLEANS, April 3, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced positive one-year results from 101 patients enrolled in the second phase of the ABSORB trial evaluating the world's first drug eluting Bioresorbable Vascular Scaffold (BVS) for the treatment of coronary artery disease. The

View More : http://www.prnewswire.com/news-releases/abbotts-absorb-bioresorbable-vascular-scaffold-demonstrates-positive-one-year-sa...
Releted News by prnewswire
Potential Treatment Found for Debilitating Bone Disease in Wounded Soldiers and Children
Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery
Gulfstream Identifies Employees Killed in G650 Crash
Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results
Home Sitemap Contact Us
© businessNewsNewsNews.com